Prosecution Insights
Prosecution Insights
8 pending office actions • 7 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (25%) |
| §103 only | 2 (25%) |
| §112 only | 1 (12%) |
| Double-patenting only | 2 (25%) |
| Double-patenting + other | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAOUD, CHRISTINE J | 1 | 58.0% | +37.6% |
| HUI, SAN MING R | 1 | 59.3% | +20.0% |
| POHNERT, STEVEN C | 1 | 12.2% | +18.7% |
| STEPHENS, AMELIA CAROLE | 1 | 80.0% | +50.0% |
| SIMMONS, CHRIS E | 1 | 34.5% | +19.3% |
| BRISTOL, LYNN ANNE | 1 | 63.6% | +39.7% |
| DEBERRY, REGINA M | 1 | 50.0% | +30.4% |
| VANHORN, ABIGAIL LOUISE | 1 | 47.0% | +22.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18248238 | METHOD FOR TREATING OX40 RELATED DISEASE | STEPHENS, AMELIA CAROLE | 49d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18619962 | METHODS FOR TREATING HYPERTENSION USING AN ANTI-BMP10 MONOCLONAL ANTIBODY OR FRAGMENT THEREOF | SAOUD, CHRISTINE J | — |
| 18300892 | METHOD FOR SELECTING CELL | POHNERT, STEVEN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916275 | ANTIBODY COMPOSITION | BRISTOL, LYNN ANNE | 59d overdue |
| 18248238 | METHOD FOR TREATING OX40 RELATED DISEASE | STEPHENS, AMELIA CAROLE | 49d overdue |
| 16608474 | OLIGONUCLEOTIDE DERIVATIVE OR SALT THEREOF | VANHORN, ABIGAIL LOUISE | 42d overdue |
| 18619962 | METHODS FOR TREATING HYPERTENSION USING AN ANTI-BMP10 MONOCLONAL ANTIBODY OR FRAGMENT THEREOF | SAOUD, CHRISTINE J | — |
| 18598208 | PHARMACEUTICAL COMPOSITION | HUI, SAN MING R | — |
| 18300892 | METHOD FOR SELECTING CELL | POHNERT, STEVEN C | — |
| 18118898 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE | SIMMONS, CHRIS E | — |
| 17288057 | PHARMACEUTICAL COMPOSITION FOR TREATING APLASTIC ANEMIA | DEBERRY, REGINA M | — |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 1627 | 1 |
| 1683 | 1 |
| 1622 | 1 |
| 1643 | 1 |
| 1647 | 1 |
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18619962 | METHODS FOR TREATING HYPERTENSION USING AN ANTI-BMP10 MONOCLONAL ANTIBODY OR FRAGMENT THEREOF | SAOUD, CHRISTINE J | 1645 | §101§102§112 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18598208 | PHARMACEUTICAL COMPOSITION | HUI, SAN MING R | 1627 | DP | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18300892 | METHOD FOR SELECTING CELL | POHNERT, STEVEN C | 1683 | §101§103§112 | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18248238 | METHOD FOR TREATING OX40 RELATED DISEASE | STEPHENS, AMELIA CAROLE | 1645 | §103 | Final Rejection | 49d overdue | Pending | Apr 06, 2023 |
| 18118898 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE | SIMMONS, CHRIS E | 1622 | §112DP | Non-Final OA | — | Pending | Mar 08, 2023 |
| 17916275 | ANTIBODY COMPOSITION | BRISTOL, LYNN ANNE | 1643 | DP | Final Rejection | 59d overdue | Pending | Sep 30, 2022 |
| 17288057 | PHARMACEUTICAL COMPOSITION FOR TREATING APLASTIC ANEMIA | DEBERRY, REGINA M | 1647 | §103 | Non-Final OA | — | Pending | Apr 23, 2021 |
| 16608474 | OLIGONUCLEOTIDE DERIVATIVE OR SALT THEREOF | VANHORN, ABIGAIL LOUISE | 1636 | §112 | Non-Final OA | 42d overdue | Pending | Oct 25, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial